Recalled Medicines & supplements – Current GIS Alerts 2026
Found 685 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Cytostin
In the medicinal product in the form of a solution for injection, crystals of unidentified origin were found, creating a real danger of administering an incorrect active substance dose or of crystals entering the patient’s bloodstream. Potential effects: lack of treatment efficacy, serious vascular complications, life‑threatening events.
Cytostin
In the medicinal product in the form of a solution for injection, visible crystals of unidentified origin were found, probably formed by crystallization of the active substance, which may result in an incorrect dose content and the crystals entering the patient’s bloodstream. Potential effects: cytostatic poisoning, lack of efficacy or thromboembolic complications.
Zodgane
The product does not meet quality requirements due to an out-of-specification result for the particle size distribution parameter D(0.9) in the nasal spray. Potential effects: possible altered drug deposition, reduced efficacy or local adverse reactions.
Symibace
Given the test results indicating significant exceedances of the specification limit for the content of impurity B, the health risk to humans from keeping these medicinal product batches on the market is real and likely. Potential effects: possible poisoning, increased adverse reactions, lack of treatment safety.
Symibace
Taking into account test results showing a significant exceedance of the specification limit for impurity B content, the risk to human health from leaving these medicinal product batches on the market is real and probable. Potential effects: toxicity, adverse reactions, therapeutic complications.
Symibace
Given the test results indicating significant exceedance of the specification limit for impurity B content, the threat to human health from leaving these batches of the medicinal product on the market is real and likely. Potential effects: poisoning, adverse reactions, cardiovascular complications.
Symibace
Considering the test results indicating a significant exceedance of the specification limit for impurity B content, the risk to human health resulting from keeping these batches of the medicinal product on the market is real and probable. Potential effects: possible toxicity, adverse effects, treatment complications.
Corsib
Unidentified degradation impurities of the active substance pose a real and direct threat to patients; due to their unconfirmed nature, a risk to the patient’s health and life cannot be excluded. Potential effects: severe adverse reactions, complications, life‑threatening events.
Corsib
Due to the unconfirmed nature of degradative impurities of the active substance, a risk to the patient’s health and life cannot be excluded; the unidentified impurities pose a real and direct threat to patients using the product. Potential effects: poisoning, unpredictable adverse reactions, lack of efficacy in treating heart disease and hypertension.
Clotidal MAX
Negative test result for the appearance parameter – damaged, chipped tablet edges and detached fragments, probably due to too low water content in the granulate and lower hardness, which may affect dose integrity and comfort of use. Potential effects: reduced treatment efficacy or irritation.
Trazodone Neuraxpharm
An out-of-specification (OOS) result was recorded for the tablet hardness parameter, potentially linked to different blister foils and gas permeability, which could affect product hardness during storage. Potential effects: possible changes in active substance release, altered bioavailability and efficacy, although the investigation showed no significant impact.
Underground Super Lemon dietary supplement (lemon-pineapple flavor)
High content of Δ9-THC in the dietary supplement. Potential effects: poisoning, psychological disturbances and health risks.
APAP dla dzieci FORTE
The suspension contains gas bubbles, is foamy and completely or almost completely fills the bottle, preventing shaking, homogenization and correct dosing of the medicinal product. Potential effects: improper dosing of paracetamol, lack of efficacy or overdose, possible adverse reactions.
APAP dla dzieci FORTE
The suspension in the bottles contained gas bubbles, was foamed, non-homogeneous and layered, and the bottles were completely or almost completely filled, which prevented shaking, homogenization and correct dosing of the medicinal product. Potential effects: incorrect paracetamol dose, lack of treatment efficacy or risk of overdose.
Tadalafil Aurovitas
The batch TGSD21011-A did not meet quality requirements due to a negative result for the parameter “release of tadalafil within 15 minutes”, which may affect treatment effectiveness. Potential effects: lack of therapeutic efficacy.
Auroverin MR
The test showed that the release of mebeverine hydrochloride was slower than allowed by quality requirements, which affects the product’s effectiveness and poses a real and direct threat to patients’ health or life. Potential effects: lack of treatment efficacy, possible worsening of symptoms, complications.
Syldenafilu cytrynian
If the description of the primary packaging of the pharmaceutical substance does not match its actual content, there is a risk of using the wrong substance in compounding a prescription medicine. An incorrect expiry date may lead to use beyond the period with guaranteed efficacy and safety. Potential effects: lack of treatment efficacy, adverse reactions, complications.
Syldenafilu cytrynian
It was found that packaging may be incorrectly labelled, including substance name, batch number and expiry date, which can lead to using the wrong raw material in compounded medicines or using it after the period guaranteeing its efficacy and safety. Potential effects: lack of treatment efficacy, adverse reactions or complications due to use of an incorrect active substance.
Autostrzykawka Morfina Przeciwko Bólowi
A problem with solution color was identified: in 4 of 92 auto-injectors the liquid was light green or green instead of colorless or pale yellow, linked to a decrease in the excipient sodium metabisulfite in batch 151021A. Potential effects: possible reduced efficacy and safety of treatment, unpredictable drug action.
Oxylaxon
A quality defect was identified involving excessively high oxycodone hydrochloride content in certain Oxylaxon prolonged-release tablet batches, caused by abnormal parameters of granulate batch EE03807. Potential effects: opioid overdose, respiratory depression, poisoning.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.